Literature DB >> 15365080

Challenging problems in malignancy: case 1. Presentation of small-cell lung cancer with marked hyperamylasemia.

Giovanni Benedetti1, Francesca Rastelli, Stefania Damiani, Cesare Calandri, Lucio Crinò.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365080     DOI: 10.1200/JCO.2004.11.099

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Amylase: sensitive tumor marker for amylase-producing lung adenocarcinoma.

Authors:  Jie Zhang; Lixia Zhang; Shiyang Pan; Bing Gu; Yuping Zhen; Jiabin Yan; Yiqin Zhou
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Biodegradable starch derivatives with tunable charge density-synthesis, characterization, and transfection efficiency.

Authors:  Carolin Thiele; Brigitta Loretz; Claus-Michael Lehr
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

3.  Hyperamylasemia Caused by the Hantaan Virus: A Retrospective Study of 101 Patients with Hemorrhagic Fever with Renal Syndrome in West China.

Authors:  Sumei Zhang; Lei Shi; Xiaoqian Jiang; Xiaoling Yang; Libo Wu; Chuan Wang; Fuchun Jing; Tianyan Chen
Journal:  Biomed Res Int       Date:  2022-06-25       Impact factor: 3.246

4.  Hypercalcemia-leukocytosis syndrome in a patient with cavitating squamous cell carcinoma of the lung.

Authors:  Olga Burzyantseva; Sanath Dharmasena; Suriya Jayawardena; Vijay A Rupanagudi; Padmanabhan Krishnan
Journal:  Cases J       Date:  2009-01-31

5.  Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report.

Authors:  Andrea Casadei Gardini; Marita Mariotti; Alessandro Lucchesi; Sara Pini; Martina Valgiusti; Sara Bravaccini; Angelo Del Monte; Marco Angelo Burgio; Giorgia Marisi; Dino Amadori; Giovanni Luca Frassineti
Journal:  BMC Cancer       Date:  2016-02-17       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.